Supplementary Figure 1 from Tobemstomig, a Novel Bispecific Antibody, Preferentially Blocks PD-1 and LAG-3 on CD8 TILs to Expand Stem-like T Cells for Sustained Tumor Control
Authors:
- Patrick A.A. WeberPWPatrick A.A. Weber
- Mario PerroMPMario Perro
- Valeria G. NicoliniVNValeria G. Nicolini
- Klas HatjeKHKlas Hatje
- Silvia JenniSJSilvia Jenni
- Stefanie BrinerSBStefanie Briner
- Esther BommerEBEsther Bommer
- Manuela TannerMTManuela Tanner
- Sylvain PiletSPSylvain Pilet
- Tamara HüsserTHTamara Hüsser
- Emilio YángüezEYEmilio Yángüez
- Stanford ChenSCStanford Chen
Open Access
- 9 July 2026
- other
- Published by American Association for Cancer Research (AACR)